Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds

Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds paxlovid Paxlovid is a ritonavir-boosted nirmatrelvir drug indicated for the treatment of mild to moderate Covid-19 in patients aged 12 years and older paxlovid Paxlovid is an oral antiviral drug that should be initiated as soon as possible within 5 days of symptom onset

paxlovid Paxlovid is an oral coronavirus medicine used in outpatient treatment for people aged 18 or over and at risk of developing the severe form of COVID-19 due to

paxlovid Paxlovid is a ritonavir-boosted nirmatrelvir drug indicated for the treatment of mild to moderate Covid-19 in patients aged 12 years and older How effective is Paxlovid for treating COVID-19? Based on studies conducted so far, Paxlovid should be prescribed within five days of symptoms